Results 51 to 60 of about 2,720 (214)

Clinical Outcomes of Collagenase Injections During a Surgeon’s Initial Learning Phase

open access: yesJournal of Hand Surgery Global Online, 2019
Purpose: Collagenase Clostridium histolyticum (CCH) has increasingly been used to treat Dupuytren contracture since its Food and Drug Administration approval in 2010. One concern among practitioners is the learning curve of this new technique. This study
John Z. Zhao, MD   +14 more
doaj   +1 more source

Connective tissue degeneration: Mechanisms of palmar fascia degeneration (Dupuytren’s disease) [PDF]

open access: yes, 2016
Dupuytren’s disease is a connective tissue disorder of the hand causing excessive palmar fascial fibrosis with associated finger contracture and disability.
Chojnowski, A.   +8 more
core   +1 more source

Squamous Cell Carcinoma and Ledderhose Disease: A Case Report [PDF]

open access: yes, 2013
Ledderhose disease is disorder of the plantar aponeurosis. This disease is not so common and can be tackled with a surgical or conservative approach.
Cherubino, M.   +5 more
core   +1 more source

Rheumatological manifestations of type 2 diabetes and its relationship to glycemic control and duration of diabetes

open access: yesSahel Medical Journal, 2014
Background: While so much emphasis is given to micro and macro vascular complications of diabetes, other long-term complications especially musculoskeletal are often overlooked and underappreciated.
Sumesh Raj   +3 more
doaj   +1 more source

Comparative Clinical and Pathomorphological Characteristics of Dupuytren’s Contracture in Men and Women

open access: yesTravmatologiâ i Ortopediâ Rossii, 2021
Background. The data available in the literature on the features of the clinical course and functional prognosis of Dupuytren`s disease in women is contradictory, there are no data on comparative pathomorphological studies of palmar fibromatosis in men ...
N. A. Shchudlo   +3 more
doaj   +1 more source

HAND PROBLEMS IN DIABETIC PATIENTS [PDF]

open access: yesBasrah Journal of Surgery, 2005
This present study was conducted on 436 diabetic patients, hand disorders were detected in 135 patients (180 hands). The incidence of Dupuytren s contracture was the highest 34%, carpal tunnel syndrome was diagnosed in 21% of the patients, flexor ...
Avadis A Muradian, Ali Iskander
doaj   +1 more source

Eliciting health state utilities for Dupuytren's contracture using a discrete choice experiment [PDF]

open access: yes, 2013
Background and purpose An internet-based discrete choice experiment (DCE) was conducted to elicit preferences for a wide range of Dupuytren’s contracture (DC)-related health states. An algorithm was subsequently developed to convert these preferences
Amaya-Amaya M   +39 more
core   +1 more source

Responsiveness of the patient-specific Canadian occupational performance measure and a fixed-items activity limitations measure in patients with dupuytren disease

open access: yesJournal of Patient-Reported Outcomes, 2023
Background Patients with Dupuytren disease experience various activity limitations. Treatment aims to reduce finger joint contractures to improve hand function and activity performance.
Anna Lauritzson   +2 more
doaj   +1 more source

Functional outcome and complications following surgery for Dupuytren’s disease: a multi-centre cross-sectional study [PDF]

open access: yes, 2016
Variables associated with recurrent Dupuytren’s disease, or a ‘diathesis’, have been investigated, but those associated with functional outcome and complications are less well studied.
B. E. Scammell   +10 more
core   +1 more source

Uncoupling TGFβ1 signalling from collagen protein synthesis in Dupuytren's disease

open access: yesThe Journal of Pathology, EarlyView.
Abstract Dupuytren's disease is a fibroproliferative disorder of the palmer fascia (PF) characterised by flexion contractures in the hand. Dupuytren's disease can be treated surgically, but disease recurrence rates are high, potentially due to continual production of matrisomal proteins.
Gabriella Cooper   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy